Original Research
Accepted on 07 Oct 2025
Residual pattern of primary tumor and lymph node in ESCC treated with nCRT with or without pembrolizumab: an analysis from a prospective cohort
in Cancer Immunity and Immunotherapy
- 141 views
Original Research
Accepted on 07 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 07 Oct 2025
in Clinical and Diagnostic Microbiology and Immunology
Original Research
Accepted on 07 Oct 2025
in Neurodevelopment
Original Research
Accepted on 07 Oct 2025
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 07 Oct 2025
in Animal Reproduction - Theriogenology
Original Research
Accepted on 07 Oct 2025
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 07 Oct 2025
in Vascular Surgery
Correction
Accepted on 07 Oct 2025
in Drugs Outcomes Research and Policies
Review
Accepted on 07 Oct 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 07 Oct 2025
in Forensic and Legal Psychology
Original Research
Accepted on 07 Oct 2025
in Advertising and Marketing Communication
Original Research
Accepted on 07 Oct 2025
in Space Physics
Brief Research Report
Accepted on 07 Oct 2025
in Asthma
Original Research
Accepted on 07 Oct 2025
in Endovascular and Interventional Neurology
Original Research
Accepted on 07 Oct 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 07 Oct 2025
in Speech and Language